Prolonged administration of dexamethasone induces limited reactivation of visceral leishmaniosis in chronically infected BALB/c mice

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 655-661

  Rousseau, Déborah ^a   Suffia, Isabelle ^a   Ferrua, Bernard ^a   Philip, Patrick ^a   Le Fichoux, Yves ^a   Kubar, Joanna ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Cytokines; Glucocorticosteroids; Immunosuppression; Leishmania persistence; T cell populations

Indexed keywords

ANTIBODY; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONTROLLED STUDY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LEISHMANIA INFANTUM; LEISHMANIASIS; LIVER; MOUSE; NONHUMAN; SPLEEN; SPLEEN CELL; STIMULATION;

ANIMALS; ANTIBODIES, PROTOZOAN; CHRONIC DISEASE; CYTOKINES; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; IMMUNOSUPPRESSIVE AGENTS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES;

ANIMALIA; LEISHMANIA INFANTUM; PROTOZOA; VERTEBRATA;

EID: 0032441746     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Aebisher T. 1994. Recurrent cutaneous leishmaniasis: a role for persistent parasites. Parasitol. Today 10: 25.
2. De Rossell R A, de Duran R J, Rossell O, Rodrigez A M. 1992. Is leishmaniasis ever cured? Trans. R. Soc. Trop. Med. Hyg. 86: 251.
3. Aebisher T, Moody S F, Handman E. 1993. Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host. Infect. Immun. 61: 220.
4. Moll H, Flohè S, Röllinghoff M. 1995. Dentritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur. J. Immunol. 25: 693.
5. Stenger S, Donhauser N, Thüring H, Röllinghoff M, Bogdan C. 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J. Exp. Med. 183: 1501.
6. Fernandez-Guerrero M L, Aguado J M, Buzon L, Barros C, Montalban C, Martin T, Bouza E. 1987. Visceral leishmaniasis in immunocompromised hosts. Am. J. Med. 83: 1098.
7. Ma D D F, Concannon A J, Hayes J. 1979. Fatal leishmaniasis in renal transplant patient. Lancet 2: 311.
8. Badaro R, Carvalho E M, Rocha H, Queiroz, A C, Jones T C. 1986. Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet 647.
9. Abdeladhim A, Ben Salem N, Gastli M, Boussen M. 1986. Mediterranean visceral leishmaniasis associated with chronic myeloid leukemia. Tunis Med. 64: 491.
10. Aguado J M, Gomez Berne J, Figuera A, de Villalobos E, Fernandez-Guerrero M L, Sanchez Fayos J. 1983. Visceral leishmaniasis (kala-azar) complicating acute leukemia. J. Infect. 7: 272.
11. Mehrotra R, Choudhry V P, Saxena R, Kapila K, Saraya A K. 1995. Asymptomatic visceral leishmaniasis in a child with acute lymphoblastic leukaemia. J. Infect. 30: 157.
12. Di Cataldo A, Lo Nigro L, Marino S, Schiliro G. 1996. Visceral leishmaniasis in three children with leukemia. Pediatr. Infect. Dis J. 15: 916.
13. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, Molina R, Moreno J. 1997. Leishmania and human immunodeficiency virus coinfection: the first 10 years. (Review) Clin. Microbiol. Rev. 10: 298.
14. Reiner S L, Locksley R M. 1995. The regulation of immunity to Leishmania major. (Review) Annu. Rev. Immunol. 13: 151.
15. + T cell function in host-parasite models. (Review) Chem. Immunol. 63: 51.
16. Reed S G, Scott P. 1993. T cell and cytokine responses in leishmaniasis. (Review) Curr. Opin. Immunol. 5: 524.
17. Müller I. 1992. Role of T cell subsets during the recall of immunologic memory to Leishmania major. Eur. J. Immunol. 22: 3063.
18. Murray H W, Squires K E, Miralles C D, Stoeckle M Y, Granger A M, Granelli-Piperno A, Bogdan C. 1992. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokines roles in initial versus established immunity. J. Immunol. 148: 1858.
19. + cells in experimental visceral leishmaniasis. J. Immunol. 140: 3971.
20. Murray H W. 1994. Blood monocytes: differing effector role in experimental visceral versus cutaneous leishmaniasis. Parasitol. Today 10: 220.
21. Shankar A H, Titus R G. 1995. T cell and non-T cell compartements can independently determine resistance to Leishmania major. J. Exp. Med. 181: 845.
22. + T lymphocytes counts. AIDS 12: 2147.
23. Chrousos G P. 1995. The hypothalamic-pituitary-adrenal axis and immune-mediated inflamation. (Review) N. Engl. J. Med. 332: 1351.
24. Wilckens T, De Rijk R. 1997. Glucocorticoids and immune function. Unknown dimensions and new frontiers. (Review) Immunol. Today 18: 418.
25. Sierra-Honigmann M R, Murphy P A. 1992. T cell receptor-independent immunosuppression induced by dexamethasone in murine T helper cells. J. Clin. Invest. 89: 556.
26. Gillis S, Crabtree G R, Smith K A. 1979. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J. Immunol. 123: 1624.
27. Gillis S, Crabtree G R, Smith K A. 1979. Glucocorticoid-induced inhibition of T. cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells. J. Immunol. 123: 1632.
28. Lew W, Oppenheim J J, Matsushima K. 1988. Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J. Immunol. 140: 1895.
29. Arya S K, Wong-Staal F, Gallo R C. 1984. Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J. Immunol. 133: 273.
30. Wu C Y, Fargeas C, Nakajiama T, Delespesse G. 1991. Glucocorticoids suppress the production of interleukin-4 by human lymphocytes. Eur. J. Immunol. 21: 2645.
31. Hennebold J D, Mu H H, Poynter M E, Chen X P, Daynes R A. 1996. Active catabolism of glucocorticoids by 11β-hydroxysteroid dehydrogenase in vivo is a necessary requirement for natural resistance to infection with Listeria monocytogenes. Int. Immunol. 9: 105.
32. Suffia I, Quaranta J F, Eulalio M C M, Ferrua B, Marty P, Le Fichoux Y, Kubar J. 1995. Human T cell activation by 14- and 18-kilodalton nuclear proteins of Leishmania infantum. Infect. Immun. 63: 3765.
33. Stauber L A. 1958. Host resistance to the Khartoum strain of Leishmania donovani. Rice Inst. Pamphlets 45: 80.
34. Rousseau D, Le Fichoux Y, Stien X, Suffia I, Ferrua B, Kubar J. 1997. Progression of visceral leishmaniasis due to Leishmania infantum in BALB/c mice is markedly slowed by prior infection with Trichinella spiralis. Infect. Immun. 65: 4978.
35. Le Fichoux Y, Rousseau D, Ferrua B, Ruette S, Lelièvre A, Grousson D, Kubar J. 1998. Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice. Antimicrob. Agents Chemother. 42: 654.
36. Wilson M E, Sandor M, Blum A M, Young B M, Metwali A, Elliott D, Lynch R G, Weinstock J V. 1996. Local suppression of IFN-γ in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 156: 2231.
37. Smelt S C, Engwerda C R, McCrossen M, Kaye M. 1997. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J. Immunol. 158: 3813.
38. Leclercq V, Lebastard M, Belkaid Y, Louis J, Milon G. 1996. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice, a tissue dependent pattern controlled by the Lsh and MHC loci. J. Immunol. 157: 4537.
39. Murray H W, Masur H, Keithly J S. 1982. Cell-mediated immune response in experimental visceral leishmaniasis. Correlation between resistance to L. donovani and lymphokine-gene-rating capacity. J. Immunol. 129: 344.
40. Murray H W, Cervia J S, Hariprashad J, Taylor A P, Stoeckle M Y, Hockman H. 1995. Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis. J. Clin. Invest. 95: 1183.
41. Murray H W, Hariprashad J. 1995. Interleukin-12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181: 387.
42. Fauci A S, Dale C. 1974. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J. Clin. Invest. 53: 240.
43. Zheng B, Han S, Zhu Q, Goldsby R, Kelsoe G. 1996. Alternative pathways for the selection of antigen-specific peripheral T cells. Nature 384: 263.
44. + subsets. J. Immunol. 155: 3322.
45. Di Rosa M, Radomski M, Carnuccio R, Moncada S. 1990. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem. Biophys. Res. Commun. 172: 1246.
46. McCall T B, Palmer R M J, Moncada S. 1991. Introduction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur. J. Immunol. 21: 2523.
47. Lemesre J L, Sereno D, Daulouède S, Veyret B, Brajon N, Vincendeau P. 1997. Leishmania spp: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms. Exp. Parasitol. 86: 58.
48. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Bécherel P, Debré P, Moncada S, Mossolayi M D. 1995. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FceRII/CD23 surface antigen. Proc. Natl Acad. Sci. USA 92: 7804.
49. Liew F Y, Millott S, Parkinson C, Palmer R M, Moncada S. 1990. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144: 4794.
50. Evans T G, Thai L, Granger D L, Hibbs J B Jr. 1993. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151: 907.
51. Stenger S, Thüring H, Röllinghoff M, Bogdan C. 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp Med. 180: 783.
52. Mirkovich A M, Galelli A, Allison A C, Modabber F Z. 1986. Increased myelopoiesis during Leishmania major infection in mice: generation of "safe targets", a possible way to evade the effector immune mechanism. Clin. Exp. Immunol. 64: 1.
53. Blank C, Bogdan C, Bauer C, Erb K, Moll H. 1996. Murine epidermal Langerhans cells do not express inducible nitric oxide synthase. Eur. J. Immunol. 26: 792.
54. Thüring H, Stenger S, Gmehling D, Röllinghoff M, Bogdan C. 1995. Lack of inducible nitric oxide synthase activity in T cell-clones and T lymphocytes from naive an Leishmania major-infected mice. Eur. J. Immunol. 25: 3229.